Old Web
English
Sign In
Acemap
>
authorDetail
>
Gianfranco Pittari
Gianfranco Pittari
Bristol-Myers Squibb
Medicine
Internal medicine
Oncology
CAR T-cell therapy
Refractory Multiple Myeloma
2
Papers
4
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
KarMMa-7, a Phase 1/2, Dose-Finding and Dose-Expansion Study of Combination Therapies with Idecabtagene Vicleucel (ide-cel, bb2121), a BCMA-Directed CAR T Cell Therapy for Relapsed/Refractory Multiple Myeloma (RRMM)
2021
Blood
Noopur Raje
Jesus G. Berdeja
Paula Rodriguez-Otero
Damian J. Green
Sundar Jagannath
Sagar Lonial
Adrianna Gipson
Andrea Caia
Nathan Martin
Zhihong Yang
Gianfranco Pittari
Maria-Victoria Mateos
Show All
Source
Cite
Save
Citations (0)
KarMMa-3: A Phase 3 Study of Idecabtagene Vicleucel (ide-cel, bb2121), a BCMA-Directed CAR T Cell Therapy Vs Standard Regimens in Relapsed and Refractory Multiple Myeloma
2020
Blood
Michel Delforge
Rachid Baz
Michele Cavo
Natalie S. Callander
Armin Ghobadi
Paula Rodriguez-Otero
Maria-Victoria Mateos
Monica Massaro
Li Ding
Payal Patel
Gianfranco Pittari
Steven Novick
Sergio Giralt
Jesus G. Berdeja
Show All
Source
Cite
Save
Citations (4)
1